Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia

Haematologica

Volumn 92, Issue 5, 2007, Pages 710-711

  Lech Maranda, Ewa ^a   Juszczynski, Przemyslaw ^a,b   Szmigielska Kaplon, Anna ^a   Jamroziak, Krzysztof ^a   Balcerczak, Ewa ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chronic lymphocytic leukemia; HLA class II; HLA DRB1; Outcome

Indexed keywords

HLA DR ANTIGEN; HLA DRB1*01 ANTIGEN; HLA DRB1*02 ANTIGEN; HLA-DRB1 ANTIGEN; HLA-DRB1*01 ANTIGEN; HLA-DRB1*02 ANTIGEN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AGED; ALLELE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; SURVIVAL; ADULT; B CELL LEUKEMIA; GENE; GENE FREQUENCY; GENETICS; IMMUNOLOGY; KAPLAN MEIER METHOD; LETTER; MIDDLE AGED; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; HLA-DR ANTIGENS; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 34447327292     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10910     Document Type: Article

References (10)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-15.
2. Gunz FW, GunzJP, Veale AM, Chapman CJ, Houston IB. Familial leukaemia: a study of 909 families. Scand J Haematol 1975;15:117-31.
3. Dorak MT, Machulla HK, Hentschel M, Mills KI, Langner J, Burnett AK. Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia. Int J Cancer 1996;65:134-9.
4. Oguz FS, Kalayoglu S, Diler AS, Tozkir H, Sargin D, Carin M, et al. HLA system affects the age-at-onset in chronic myeloid leukemia. Am J Hematol 2003;73:256-62.
5. Juszczynski P, Kalinka E, Bienvenu J, Woszczek G, Borowiec M, Robak T, et al. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin's lymphoma outcome. Blood 2002;100:3037-40.
6. Machulla HK, Muller LP, Schaaf A, Kujat G, Schonermarck U, Langner J. Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients. Int J Cancer 2001;92:203-7.
7. Hus I, Rolinski J, Tabarkiewicz J, Wojas K, Bojarska-Junak A, Greiner J, et al. Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia. Leukemia 2005;19:1621-7.
8. Kokhaei P, Rezvany MR, Virving L, Choudhury A, Rabbani H, Osterborg A, et al. Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL. Leukemia 2003; 17:894-9.
9. Nuckel H, Rebmann V, Durig J, Duhrsen U, Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005;105:1694-8.
10. Hviid TV, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G: possible implications for human reproduction and autoimmune disease. Hum Immunol 2005;66:688-99.